Powered by
-
JNJ Stock Chart
Historical JNJ Prices
Johnson & Johnson Stock Analysis
Rating: Strong Buy
Total Grade: A
Analysis Breakdown
| JNJ Stock Grade: | A |
| Fundamental Grade: | C |
| Quantitative Grade: | A |
| JNJ Earnings | |
| Earnings Growth: | D |
| Earnings Momentum: | C |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | B |
| JNJ Financial Information | |
| Sales Growth: | B |
| Operating Margin Growth: | D |
| Cash Flow: | C |
| Return on Equity: | A |
Johnson & Johnson Stock: Weekly View
| This Week: | A |
|---|---|
| Last Week: | B |
| Two Weeks Ago: | B |
JNJ Stock predictions, Articles, and Johnson & Johnson News
- From InvestorPlace
- From the Web
-
Johnson & Johnson’s (JNJ) Strong Quant Score Makes it a Buy - October 20, 2017
Johnson & Johnson Co (NYSE:JNJ) is ranked as a Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking JNJ has had from Portfolio Grader for 7 months. Continue…
-
Dow Jones Industrial Average Hits 23,000. Now What? - October 18, 2017
The Dow Jones Industrial Average is definitely overbought. I wouldn't be a buyer, but staying long could have its advantages. Continue…
-
Johnson & Johnson (JNJ) Beat Q3 Earnings, Ups Forecast - October 17, 2017
Johnson & Johnson (JNJ) stock was up today following the release of a positive earnings report for the third quarter of the year. Continue…
-
5 Can’t-Miss Dow Jones Stocks to Buy Today - October 11, 2017
These five Dow Jones stocks are perking up today. Here's everything you need to know to about how and where they're trending. Continue…
-
Buy Ranking for Johnson & Johnson (JNJ) Kept - October 6, 2017
Johnson & Johnson Co (NYSE:JNJ) is ranked as a Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking JNJ has had from Portfolio Grader for 6 months. Continue…
-
How Will Trump’s Proposed Tax Reform Impact Drug Companies? - September 29, 2017
Donald Trump has proposed new tax reforms for individuals and corporates. Let’s see how the reforms, if passed, will impact pharma companies. Continue…
-
Gilead Sciences, Inc. (GILD) Stock Got Its Mojo Back - September 29, 2017
For a while GILD stock was a hideous knife to catch. But now that it reestablished its bottom, I can safely make money in Gilead. Continue…
-
The 10 Safest Blue-Chip Dividend Stocks for the Rest of the Year - September 26, 2017
If you're looking to round out the year and your portfolio with some dependable income, these dividend stocks are for you! Continue…
-
5 Types of Stocks for Your Portfolio’s Midlife Crisis - September 18, 2017
As you grow older, value matters more and more. Here's a gameplan -- and some specific stocks to buy -- to navigate an ever-changing market. Continue…
-
Supercharge Your Portfolio With Amgen, Inc. (AMGN) Stock - September 12, 2017
Wall Street goes on buying sprees into the biotech sector. Take advantage of this run to profit from red hot AMGN Stock. It's headed higher. Continue…
